» Articles » PMID: 18547024

[Diagnostics and Treatment of Cholangiocarcinoma]

Overview
Specialty General Medicine
Date 2008 Jun 13
PMID 18547024
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

--Cholangiocarcinoma is a rare malignancy originating from the biliary epithelium. The disease can arise anywhere in the biliary tract: intrahepatic, perihilar or distal. The overall prognosis for cholangiocarcinoma is poor. --The treatment necessitates a multidisciplinary approach. --Radical resection of the extrahepatic bile ducts, usually in combination with concomitant partial liver resection, remains the only curative treatment. --Liver transplantation in combination with neoadjuvant chemoradiation therapy seems to be promising in a highly selected group of patients. --Palliative treatment should be targeted at adequate biliary drainage, preferably by stenting. --Radiotherapy and systemic chemotherapy are not standard treatment and should be applied in an experimental setting only. --New options such as photodynamic therapy and tyrosine kinase inhibitors are promising, but still experimental treatments.

Citing Articles

5-aminolevulinic acid-incorporated poly(vinyl alcohol) nanofiber-coated metal stent for application in photodynamic therapy.

Yoo J, Kim C, Chung C, Jeong Y, Kang D Int J Nanomedicine. 2012; 7:1997-2005.

PMID: 22619537 PMC: 3356192. DOI: 10.2147/IJN.S30298.